About Company |
Established in 2011, as a private limited company registered under Companies Act, 1956, we are quickly growing towards creating a vast impact on the healthcare industry. THey are set with cutting-edge infrastructure which allows us to effect our products’ quality, safety and efficacy. These attributes are the basis of our commitment to patients, and of our abiding efforts to making the difference. Their product offerings deliver at realistic prices in regulated markets around the world.
It is presently engaged in more than 30 API development projects and plans are underway to work on NCE's in the near future. They offer more than 20 generic drug substances for a variety of health issues including oncology, anti-diabetic, and antimicrobials. They have the ability to manufacture peptide API's from gram to kilogram scale and small molecules from gram scale to tons.
|